Thanh bên bài viết

PDF
Ngày xuất bản: 18/04/2023
Số lượt xem tóm tắt: 95
Số lượt xem PDF: 114
DOI: https://doi.org/10.51298/vmj.v525i1.5046
Số xuất bản
Tập 525 Số 1 (2023): Vietnam Medical Association
Chuyên mục
Các bài báo
Trích dẫn bài báo
Hong Son, T. ., Xuan Ninh, N. ., Lien Huong, L. ., Minh Khanh, L. ., & Bich Nga , P. . (2023). BODY COMPOSITIONS AND ITS ASSOCIATION WITH DISLIPIDEMIA IN OVERWEIGHT/OBESE ADULTS AGED 40-60 IN HANOI. Tạp Chí Y học Việt Nam, 525(1). https://doi.org/10.51298/vmj.v525i1.5046

BODY COMPOSITIONS AND ITS ASSOCIATION WITH DISLIPIDEMIA IN OVERWEIGHT/OBESE ADULTS AGED 40-60 IN HANOI

Hong Son Truong 1,, Xuan Ninh Nguyen 1, Lien Huong Luu 1, Minh Khanh Le 1, Bich Nga Phan 2
1 Vietnam Institute of Applied Medicine
2 National University of Nutrition

Nội dung chính của bài viết

Tóm tắt

To describe the body composition of overweight/obese adults and its association with some blood lipid index in overweight/obese adults in Hanoi. Method: A cross sectional study among 80 overweight/obese adults aged 40-60 in Hanoi, from August, 2020 to October, 2020. Results: Among overweight and obese people, the percentage of high cholesterol were 57,5%, the percentage of high LDL cholesterol were 65,0%, the percentage of high triglyceride were 58,8%. Linear regression showed that there were positive associations between LDL cholesterol with body fat mass, percent body mass and visceral fat (p<0.05) and negative association between HDL cholesterol with weight, BMI index, body fat mass, and visceral fat (p<0.05). Conclusions: The percentage of total cholesterol, high LDL cholesterol and triglyceride among overweight and obese people in Hanoi were high (57,5%, 65,0% and 58,8%, respectively). Some body composition indexes might have correlation with blood lipid indexes, but further studies need to be done to confirm these correlations.

Chi tiết bài viết

Từ khóa

overweight, obesity, hyperlipidemia, body composition, dyslipidemia

Tài liệu tham khảo

1. Feingold KR. Obesity and Dyslipidemia. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000- 2020; Available from: https://www.ncbi.nlm.nih.gov/books/NBK305895/.
2. Hội Tim mạch học Quốc gia Việt Nam, Rối loạn lipid máu và nguy cơ bệnh tim mạch.
3. Tolonen H, et al., Prevalent aweness and treatment of hypercholessterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol, 2005. 34(1): p. 181-192.
4. Jean-Pierre Després, et al., Abdominal obesity: The cholesterol of the 21st century? Canadian Journal of Cadiology, 2008. 24: p. 7-12.
5. Lozano, P., et al., Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 2016. 316(6): p. 634-44.
6. Chan DC, Barrett HP, and Watts GF, Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs. , 2004. 4(4).
7. Després JP, et al., Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. . Arterioscler Thromb Vasc Biol., 2009. 29(416-423).